Your browser doesn't support javascript.
loading
Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching.
Chen, Chen; Zhao, Shujie; Zhao, Xiangru; Cao, Lin; Karnad, Anand; Kumar, Addanki P; Freeman, James W.
Afiliação
  • Chen C; Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Life Science and Health Engineering, Jiangnan University, 214122, Wuxi, P. R. China.
  • Zhao S; Department of Medicine, Division of Hematology and Oncology, University of Texas Health, San Antonio, TX, USA.
  • Zhao X; Department of Medicine, Division of Hematology and Oncology, University of Texas Health, San Antonio, TX, USA.
  • Cao L; Department of Medicine, Division of Hematology and Oncology, University of Texas Health, San Antonio, TX, USA.
  • Karnad A; Department of Medicine, Division of Hematology and Oncology, University of Texas Health, San Antonio, TX, USA.
  • Kumar AP; Department of Medicine, Division of Hematology and Oncology, University of Texas Health, San Antonio, TX, USA.
  • Freeman JW; Mays Cancer Center at UT Health San Antonio-MD Anderson Cancer Center, San Antonio, TX, USA.
Cell Death Dis ; 13(8): 682, 2022 08 05.
Article em En | MEDLINE | ID: mdl-35931675
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Antimetabólitos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Antimetabólitos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article